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Background: Well-designed trials of strategies to improve adherence to clinical practice guidelines are needed to
close persistent evidence-practice gaps. We studied how the number of these trials is changing with time, and to
what extent physicians are participating in such trials.
Methods: This is a literature-based study of trends in evidence-practice gap publications over 10 years and
participation of clinicians in intervention trials to narrow evidence-practice gaps. We chose nine evidence-based
guidelines and identified relevant publications in the PubMed database from January 1998 to December 2007. We
coded these publications by study type (intervention versus non-intervention studies). We further subdivided
intervention studies into those for clinicians and those for patients. Data were analyzed to determine if observed
trends were statistically significant.
Results: We identified 1,151 publications that discussed evidence-practice gaps in nine topic areas. There were 169
intervention studies that were designed to improve adherence to well-established clinical guidelines, averaging 1.9
studies per year per topic area. Twenty-eight publications (34%; 95% CI: 24% - 45%) reported interventions
intended for clinicians or health systems that met Effective Practice and Organization of Care (EPOC) criteria for
adequate design. The median consent rate of physicians asked to participate in these well-designed studies was
60% (95% CI, 25% to 69%).
Conclusions: We evaluated research publications for nine evidence-practice gaps, and identified small numbers of
well-designed intervention trials and low rates of physician participation in these trials.
Background
Many clinical guidelines have not been fully implemen-
ted in clinical practice, despite widespread acceptance of
evidence-based recommendations by the medical com-
munity [1-21]. Closing these ‘evidence-practice gaps’
would result in significant improvements in public
health. This outcome is desirable, but requires removal
of barriers at the level of the patient, physician, medical
organization, and socioeconomic or political community
[22,23].
Researchers and clinicians who identify specific bar-
riers to guideline adoption and then design interventions
to purposefully overcome them are most likely to affect
change [24]. This process requires well-designed trials
to identify the most successful strategies for change.
This type of research is called ‘knowledge translation’ or
T2, ‘the translation of results from clinical studies into
everyday clinical practice and health decision making’
[25]. Funding for T2 research lags significantly behind
that for technological innovations, despite estimates that
health outcomes are more likely to improve with univer-
sal adoption of already proven guidelines [26,27].
Despite the absence of proven strategies for guideline
implementation, physicians are expected to successfully
adopt guidelines into their practices. Physicians are held
accountable for evidence-practice gaps when their prac-
tices are measured by internal quality reviews, insurance
companies and government entities, (e.g., ‘pay for per-
formance’) [28].
We hypothesized that the demand on physicians and
health systems for improved patient outcomes would
create demand for evidence-based methods for incor-
porating guidelines into clinical practice. We expected
that the number of methodologically rigorous trials
examining the differential effectiveness of strategies to
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care systems would increase over time. We also
expected that there would be high levels (>75%) of clini-
cian participation in such trials.
Methods
Literature search
We conducted a literature search to identify relevant
publications. We examined English language studies
regarding nine guidelines (Table 1) from January 1998
to December 2007 by performing a computer-based lit-
erature search of the PubMed data base with the follow-
ing search terms: (clinical performance OR attitude OR
knowledge OR evidence practice gap OR practice guide-
lines as topic* [mh] OR guideline adherence [mh] OR
clinical practice guideline* OR guideline* [title] OR
recommendation* OR adherence OR best practice* OR
implementation OR know to do gap OR knowledge
translation) AND ((’1998/01/01’ [PDat]: ‘2007/12/31’
[PDat]) AND (English [lang])) AND (topic area term).
The first and second authors selected the nine practice
guidelines for analysis. Guidelines met all of the follow-
ing criteria: each guideline was broadly applicable to the
practice of family medicine; each guideline was sup-
ported by well-designed clinical trials; and we could
identify a persistent evidence-practice gap for each
guideline [1-10,16-21]. A persistent gap was determined
to be present if demographic studies quantified a gap
prior to January 1998 and after December 2007 and are
referenced in Table 1. Analysis was limited to the prac-
tice recommendations listed in Table 1. Other practice
recommendations included in the referenced guidelines
were not included in this analysis.
Article classification
We initially divided articles in each of nine topics into
two categories: intervention studies and non-interven-
tion studies or publications. Intervention studies were
defined as those that evaluated strategies to close the
evidence-practice gap by changing patient or clinician
attitudes, clinical behavior, and/or knowledge. If a publi-
cation incorporated intervention and non-intervention
elements, it was included as an intervention study.
We further subdivided intervention studies based on
the target of the intervention (patient or clinician).
‘Patient’ studies were defined as those that had the
intervention applied to patients or family caregivers of
patients. For example, a trial that compared rates of
mammography in women randomized into two groups
(advising by lay health advisors versus no intervention)
would be a ‘patient’ study. ‘Clinician’ studies were
defined as those that had interventions applied to clini-
cians or the health system. For example, a trial that
compared antibiotic prescribing practices of physicians
randomized into two groups (guideline dissemination by
mail versus discussion of guidelines in a small group of
physicians) would be a ‘clinician’ study.
We classified a study that evaluated interventions tar-
geting both patients and clinicians as a ‘clinician’ study.
We then classified ‘clinician’ intervention studies using
standard Effective Practice And Organization Of Care
(EPOC) criteria for research design into ‘well-designed
studies’ (EPOC criteria 1.1-1.2, inclusive, describing ran-
domized controlled trials (RCTs), controlled clinical
trials, controlled before and after studies with adjust-
ment for confounders, and interrupted time series) [29]
and ‘other studies’ (any studies that did not meet EPOC
criteria for adequate research design).
We subdivided non-intervention publications based on
primary content (editorial, descriptive study, or treat-
ment guideline). ‘Editorial’ publications were defined as
non-data-based studies offering commentary on a facet
of the evidence-practice gap. ‘Descriptive studies’ were
data-based examinations of the evidence-practice gap,
such as studies of epidemiology or sociodemographic
factors, but did not evaluate any intervention strategy.
‘Treatment guidelines’ were defined as publications that
described current treatment recommendations or clini-
cal guidelines and did not report original research. Stu-
dies that examined the efficacy of treatment
recommendations were excluded. Ten percent of the
abstracts were randomly selected and type of study inde-
pendently re-coded to provide an estimate of inter-rater
reliability.
Statistical Methods
We investigated: whether the total number of evidence-
practice gap publications that evaluated intervention
strategies designed to improve clinician adherence to
Table 1 Medical guidelines selected for analysis
Topic Guideline
ACE inhibitors ACE inhibitors are the agent of choice in treatment
of hypertension in diabetes mellitus.
Beta-blockers Beta blockers should be prescribed to patients who
have experienced a myocardial infarction.
Asthma Inhaled anti-inflammatory agents should be used in
patients with persistent asthma.




















Adult women should have regular mammograms.
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tion of these publications that were intervention studies
increased over time; the proportion of these interven-
tions that would be adequate as defined by EPOC cri-
teria for experimental design [29]; and clinician
participation in well-designed intervention trials.
The number of publications for each topic and type of
study are presented. Given the small number of publica-
tions, studies were collapsed across topic areas and ana-
lysis undertaken on the pooled studies for the remaining
analyses.
We undertook linear regression analysis of the num-
ber of evidence-practice gap articles versus time. A
regression coefficient that was statistically significantly
different from zero indicated an increase in the number
of publications over time. We used the Cochran-Armi-
tage Trend Test to determine whether the proportion of
selected evidence-practice gap publications that were
classified as intervention studies increased over time.
The percentage of clinician-focused intervention stu-
dies that used an adequate design (by EPOC criteria)
was calculated with a 95% confidence interval (CI). If
the lower limit of the confidence interval is greater than
75%, then we can conclude that the proportion of inter-
vention studies that are RCTs is greater than a hypothe-
sized value of 75%. Seventy-five percent was pre-
specified in this analysis by consensus of the authors
that this figure represented a clear majority of studies.
The median clinician consent rate for all studies tar-
geting clinician adherence to best practice was calcu-
lated with a 95% confidence interval and compared to a
hypothesized value of 75%.
Inter-rater reliability
We calculated the Kappa statistic to assess agreement
between the two raters on type of study.
No approval was required by a human-subjects review
board.
Results
For the nine medical guidelines, we identified 1,151 rele-
vant publications from January 1998 to December 2007.
Total number of evidence-practice gap studies over time
The number of studies on the evidence-practice gap in
the defined areas varied from 85 in 1998 to a high of 145
in 2003 (Tables 2 and 3). The slope of the simple linear
regression model for total number of evidence-practice
gap studies versus year was 2.10 (95% CI, -2.46 to 6.66),
indicating no statistically significant increase over time.
Proportion of intervention trials compared to total
evidence-practice gap studies
We found 169 intervention studies (15%) and 982 non-
intervention studies (85%) (Tables 2 and 3). The percen-
tage of all evidence-practice gap publications that
involved intervention studies ranged from a minimum
of 8.5% in 2001 to a maximum of 23% in 2006, a trend
over time that was marginally non-significant (Cochran
Armitage Trend Test Z = 1.9514, p = 0.0510).
Proportion of intervention studies that were well-
designed
Of the 169 intervention trials, 87 (51%) were intended
for patients and 82 (49%) were intended for clinicians.
Of the 82 interventions intended for clinicians, 28 (34%;
95% CI, 24% to 45%) met the EPOC criteria for well-
designed studies. Thus, the majority of intervention stu-
dies for clinicians do not meet EPOC criteria for well-
designed studies. Of the studies that met EPOC criteria,
there were 14 RCTs, two controlled clinical trials, five
controlled before-and-after studies, and seven inter-
rupted time designs. The most common reason for fail-
u r et om e e tE P O Cc r i t e r i af o rg o o dd e s i g nw a st h e
inclusion of only one data point measurement of adher-
ence to best practices before and after introduction of a
guideline (28 of 54 studies). The remaining studies that
failed to meet EPOC criteria were surveys, interviews,
pilot projects, and observational studies.
Clinician consent rate in well-designed intervention
studies
Only 11 of the 28 clinician-focused evidence-practice
gap intervention studies meeting the EPOC criteria were
included in this analysis, as 13 studies did not mention
consent rates and four studies listed consent at the level
of the physician practice or peer group rather than the
individual physician. The median consent rate for well-
designed studies targeting clinician adherence to best
practice was 60% (95% CI, 25-69%), which was not
greater than the hypothesized value of 75%.
Inter-rater reliability
In all, 109 publications were independently re-classified
by type of study resulting in a Kappa of 0.85 (95% CI,
0.77 to 0.93).
Discussion
We examined publications of the last ten years related
to the persistent evidence-practice gap in nine medical
topic areas. We chose these topic areas because each
guideline is supported by well-designed clinical trials
and has been accepted by the medical community for a
minimum of ten years [1-4,7-10]. Despite widespread
support for routine use of these guidelines to decrease
morbidity, mortality, and/or costs, an ongoing evidence-
practice gap is identified for each guideline [5,6,11-21].
If the evidence-practice gaps were closing, it would be
reasonable that further study of interventions or how to
adopt them would not be needed. Because we document
that gaps in all nine clinical topic areas are persisting,
we expect that meaningful research would be ongoing.
This research should include trials of strategies to affect
change [24]. In contrast, we document with this study
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defined evidence-practice gaps did not significantly
increase (2.10, 95% CI, -2.46 to 6.66). Our analysis
demonstrated a marginally non-significant increase over
time in the proportion of evidence-practice gap studies
that were intervention studies, indicating that there may
be some evidence of an increasing trend. However, the
total number of intervention studies remained surpris-
ingly low (an average of 1.9 intervention trials per year
per topic area). The majority (53%) of publications over
a ten-year period fell instead into the ‘descriptive’ cate-
gory (see Methods for classification parameters).
Although data-based, descriptive studies can only define
or highlight problems rather than test solutions.
Reasons for the limited number of interventions were
not identified by this study, but other reviews suggest
ethical concerns, funding restrictions, and degree of dif-
ficulty in completing controlled trials compared with
descriptive studies [22,23,26,27].
Moving beyond observational studies, pre-post evalua-
tions, and pilot studies to well-controlled research is
necessary to obtain valid and generalisable results.
However, we found few of these high-quality studies. Only
28 studies in nine subject areas over a ten-year period
were well-designed studies evaluating strategies that clini-
cians or health systems could use to improve adherence to
best practices. These 28 studies represent 16% of the total
intervention studies, and only 2.4% of all of the evidence-
practice gap publications in the nine topic areas.
The research patterns we describe above are discoura-
ging, and it would be easy as a practicing physician to
lay blame on the researchers or funding agencies design-
ing and/or choosing which grants to support. It is also
reasonable that a practicing physician may decline to
participate in sloppy or frivolous research. However, this
study documents low participation rates in clinician
intervention studies that met EPOC criteria for adequate
design. The median physician consent rate in well-con-
trolled trials was 60% (95% CI, 25 to 69%).
Physicians may not participate in intervention trials
for many reasons, including financial or time con-
straints, failure to be invited to participate, lack of inter-
est, and disagreement about the medical merits of the
intervention or research goal. A clinician may also
refuse due to more psychologically complex issues: trial
participation requires an acknowledgement that evi-
dence-practice gaps exist and a willingness to let others
dictate one’s behavior. Physicians may also lack confi-
dence that they are suitable agents of change for these
guidelines. However, the medical community expects
patients to readily participate in clinical trials so that
valid and generalisable results are obtained. Physicians
should be held to the same standard of participation.
Limiting the search to the PubMed database may have
resulted in missing some relevant publications, but it is
likely that a high-quality study would be published in a
peer-reviewed journal catalogued in PubMed. The
choice of medical guidelines may also affect the search
results, but a similar pattern of limited high-quality
interventions was seen in every guideline examined.
Table 2 Number of intervention studies by year and topic
Year 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Total
Topic
Mammograms 7 8 3 2 9 5 5 11 4 8 62
Beta-blockers 2 4 0 3 1 13032 1 9
Atrial fibrillation 0 3 0 0 1 01124 1 2
ACE inhibitors 0 0 0 0 0 110103
Pain in cancer patients 0 1 0 0 0 010002
Cervical cancer screening 1 0 0 0 0 000113
Smoking in pregnancy 1 0 4 3 4 32032 2 2
Antibiotics for URTI 0 3 4 3 5 34668 4 2
Asthma 0 1 0 0 1 010104
TOTAL 11 20 11 11 21 13 18 18 21 25 169





studies (percent of total studies)
1998 85 11 (13%)
1999 114 20 (18%)
2000 102 11 (11%)
2001 129 11 (8.5%)
2002 113 21 (19%)
2003 145 13 (9.0%)
2004 123 18 (15%)
2005 117 18 (15%)
2006 93 21 (23%)
2007 130 25 (19%)
Total 1151 169 (15%)
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Evidence-practice gaps for nine well-established medical
guidelines have persisted for the past ten years. Publica-
tions regarding these gaps are consistently descriptive in
nature or simply restate treatment recommendations,
with few rigorous trials of methods for closing the evi-
dence-practice gap. The scarcity of high-quality inter-
vention trials and low physician participation in these
trials decrease the likelihood of closing the evidence-
practice gap. This research pattern is insufficient to cre-
ate successful strategies for implementing best practices.
Instead, physicians are left without reliable means to
improve their patients’ health or means to meet the
demand for improved health outcomes from employers
and insurers. A new research pattern of evaluating stra-
tegies for changing clinical behavior and the functioning
of health care systems is needed. Individual clinicians
should contribute to translational research by readily
agreeing to participate in these trials.
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